Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
23.04
-1.18 (-4.87%)
At close: Sep 4, 2026

SHA:688806 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
553.93515.37559.41594.72758.35
Short-Term Investments
---30.81-
Cash & Short-Term Investments
553.93515.37559.41625.53758.35
Cash Growth
--7.87%-10.57%-17.51%-
Accounts Receivable
50.8683.14--16.31
Other Receivables
3.123.012.381.681.61
Receivables
53.9786.152.381.6817.92
Inventory
110.9695.1657.5325.0823.18
Other Current Assets
63.9941.959.6211.5432.03
Total Current Assets
782.86738.63628.96663.82831.47
Property, Plant & Equipment
187.43190.42219.13230.81215.27
Long-Term Investments
--12.2111-
Other Intangible Assets
5.435.362.863.53.61
Long-Term Deferred Charges
9.715.3635.3664.3989.13
Other Long-Term Assets
56.8628.7234.7818.4111.97
Total Assets
1,042978.5933.3991.931,151

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
24.6735.6593.2128.9335.37
Accrued Expenses
31.1451.5329.2922.7117.88
Short-Term Debt
46.9867.0171.1928.0330.03
Current Portion of Long-Term Debt
-216.7164.32.9719.29
Current Portion of Leases
-11.4712.659.6214.01
Current Income Taxes Payable
----0
Current Unearned Revenue
14.1658.77817.629.9
Other Current Liabilities
311.1811.656.736.737.85
Total Current Liabilities
428.13452.79285.38116.61134.33
Long-Term Debt
492.88363.74208.15111.5932.01
Long-Term Leases
35.1536.9745.9851.4224.15
Long-Term Unearned Revenue
8.519.3410.74--
Total Liabilities
964.67862.84550.25279.63190.49

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
391.46391.46371.2360148.62
Additional Paid-In Capital
1,3101,162859.5685.231,896
Retained Earnings
-1,648-1,449-847.7-332.93-1,083
Comprehensive Income & Other
-1.71-0.490.050-0.02
Total Common Equity
51.36103.66383.05712.3960.96
Minority Interest
26.2512.01---0
Shareholders' Equity
77.61115.66383.05712.3960.96
Total Liabilities & Equity
1,042978.5933.3991.931,151

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
575.01695.91402.27203.64119.5
Net Cash (Debt)
-21.08-180.53157.14421.9638.86
Net Cash Growth
---62.75%-33.96%-
Net Cash Per Share
-0.05-0.470.431.343.99
Filing Date Shares Outstanding
390.31391.46371.2314.41159.95
Total Common Shares Outstanding
390.31391.46371.2314.41159.95
Working Capital
354.72285.84343.58547.21697.14
Book Value Per Share
0.130.261.032.276.01
Tangible Book Value
45.9398.29380.18708.8957.36
Tangible Book Value Per Share
0.120.251.022.255.99
Machinery
-242.09236.55215.04205.79
Construction In Progress
-1.491.728.575.42